Veterinary and Comparative Oncology

Article	Citations
Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats	107
The development of an indirect computed tomography lymphography protocol for sentinel lymph node detection in head and neck cancer and comparison to other sentinel lymph node mapping techniques	27
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tu	25
Contrast‐enhanced ultrasound for sentinel lymph node mapping in the routine staging of canine mast cell tumours: A feasibility study	23
Use of indirect computed tomography lymphangiography to determine metastatic status of sentinel lymph nodes in dogs with a pre‐operative diagnosis of melanoma or mast cell tumour	23
Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs	18
Safety evaluation of the canine osteosarcoma vaccine, live Listeria vector	17
Evaluation of a modified proportional margin approach for complete surgical excision of canine cutaneous mast cell tumours and its association with clinical outcome	17
Peripheral blood cell ratios as prognostic factors in canine diffuse large B‐cell lymphoma treated with CHOP protocol	17
Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours	16
Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy	15
Cyclooxygenase‐2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas	14
Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas	14
Clinicopathological characteristics and prognostic factors for canine multicentric non‐indolent T‐cell lymphoma: 107 cases	14
Outcome after surgical management of canine insulinoma in 49 cases	13
To map or not to map the cN0 neck: Impact of sentinel lymph node biopsy in canine head and neck tumours	13
Outcome in dogs undergoing adrenalectomy for small adrenal gland tumours without vascular invasion	12
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report	12
Histologically low‐grade, yet biologically high‐grade, canine cutaneous mast cell tumours: A systematic review and meta‐analysis of individual participant data	12
Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma	12
Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology study	12
Clinical outcome in 23 dogs with exocrine pancreatic carcinoma	12
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retro	11
Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B‐cell lymphoma	11
Efficacy of frameless stereotactic radiotherapy for the treatment of presumptive canine intracranial gliomas: A retrospective analysis (2014‐2017)	11

Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate	10
Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases	10
Neutrophil‐to‐lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas	10
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria	10
Kynurenine 3‐monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survi	10
Statins downregulateYAPandTAZand exert anti‐cancer effects in canine mammary tumour cells	9
Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta‐analysis	9
Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?	9
Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials	9
Prognostic impact of clinical, haematological, and histopathological variables in 102 canine cutaneous perivascular wall tumours	9
Integrated analysis of transcriptome, methylome and copy number aberrations data of marginal zone lymphoma and follicular lymphoma in dog	9
A newly established canine NK‐type cell line and its cytotoxic properties	9
Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases	9
Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes	9
miR‐497 induces apoptosis by the IRAK2/NF‐κB axis in the canine mammary tumour	8
Adherence to follow‐up recommendations for dogs with apocrine gland anal sac adenocarcinoma: A multicentre retrospective study	8
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review	8
Evaluation of accuracy for 18F‐FDG positron emission tomography and computed tomography for detection of lymph node metastasis in canine oral malignant melanoma	8
Characterizing the molecular and immune landscape of canine bladder cancer	8
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)	8
The effect of cannabidiol on canine neoplastic cell proliferation and mitogen‐activated protein kinase activation during autophagy and apoptosis	8
The oncogenic pathways of papillomaviruses	8
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐anti	8
Response‐based modification of CHOP chemotherapy for canine B‐cell lymphoma	7
Long non‐coding RNA and transfer RNA‐derived small fragments in exosomes are potential biomarkers for canine oral melanoma	7
Unconventional diets and nutritional supplements are more common in dogs with cancer compared to healthy dogs: An online global survey of 345 dog owners	7
The feasibility and utility of optical coherence tomography directed histopathology for surgical margin assessment of canine mast cell tumours	7
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)	7
Outcome, prognostic factors and histological characterization of canine gastrointestinal sarcomas	7
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours	7
Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma	7
Canine mammary tumours: Size matters–a progression from low to highly malignant subtypes	7
Intraoperative assessment of canine soft tissue sarcoma by deep learning enhanced optical coherence tomography	7
Fasting reduces the incidence of vincristine‐associated adverse events in dogs	7
One‐year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer	7
Feline and canine Merkel cell carcinoma: A case series and discussion on cellular origin	6
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study	6
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours	6
Response and outcome following radiation therapy of macroscopic canine plasma cell tumours	6
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey	6
Post‐operative complications following apocrine gland anal sac adenocarcinoma resection in dogs	6
Are B‐symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B‐cell lymphoma	6
JARID1‐targeted histone H3 demethylase inhibitors exhibit anti‐proliferative activity and overcome cisplatin resistance in canine oral melanoma cell lines	6
Carboplatin‐induced myelosuppression as related to body weight in dogs	6
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy	6
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas	6
Minimally invasive ethyl cellulose ethanol ablation in domesticated cats with naturally occurring head and neck cancers: Six cats	6
Canine tonsillar neoplasia and tonsillar metastasis from various primary neoplasms	6
Long‐term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart‐base tumours in dogs	5
A prospective, multi‐centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine na	5

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model	5
An open‐label dose escalation study evaluating tolerability and safety of a single 5‐days course of temozolomide in dogs with advanced cancer	5
Focused ultrasound tumour ablation in small animal oncology	5
Optical coherence tomography imaging of excised canine apocrine gland anal sac adenocarcinoma tumours	5
Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma	5
Evaluating optical coherence tomography for surgical margin assessment of canine mammary tumours	5
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component	5
Development of synthetic microRNA‐214 showing enhanced cytotoxicity and RNase resistance for treatment of canine hemangiosarcoma	5
Histologic grade has a higher‐weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes	5
Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non‐neoplastic mucosa: A preliminary study	5
Chemotherapy‐induced diarrhoea in dogs and its management with smectite: Results of a monocentric open‐label randomized clinical trial	5
Ki‐67 assessment—agreeability between immunohistochemistry and flow cytometry in canine lymphoma	5
Outcome and postoperative complications in 73 dogs with thyroid carcinoma with gross vascular invasion managed with thyroidectomy	5
Thymic epithelial tumours in 51 dogs: Histopathologic and clinicopathologic findings	5
Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case–control study	5
Prognostic value of pretreatment plasma D‐dimer level in dogs with intermediate to high‐grade non‐Hodgkin lymphoma	5
Treatment outcomes and target delineation utilizing CT and MRI in 13 dogs treated with a uniform stereotactic radiation therapy protocol (16 Gy single fraction) for pituitary mas	5
Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence	5
SLUG is upregulated and induces epithelial mesenchymal transition in canine oral squamous cell carcinoma	4
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma	4
Sarcomas—A barren immunological wasteland or field of opportunity for immunotherapy?	4
Veterinary oncologists adapting to COVID‐19 pandemic	4
Tn and Sialyl‐Tn antigens in canine gastric tissues	4
Comparison of pathologist review protocols for cytologic detection of prostatic and urothelial carcinomas in canines: A bi‐institutional retrospective study of 298 cases	4
A retrospective analysis on the outcome of 18 dogs with malignant ovarian tumours	4
Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines	4
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles	4
Highly recurrent BRAF p.V595E mutation in canine papillary oral squamous cell carcinoma	4
Retrospective assessment of radiation toxicity from a definitive‐intent, moderately hypofractionated image‐guided intensity‐modulated protocol for anal sac adenocarcinoma in dogs	4
DNA damage response proteins in canine cancer as potential research targets in comparative oncology	4
Efficacy and adverse events of continuous l‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin	4
Outcomes of cats treated with maxillectomy: 60 cases. A Veterinary Society of Surgical Oncology retrospective study	4
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway	4
Plasma 25‐hydroxyvitamin D and the inflammatory response in canine cancer	4
Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology‐Pathology Working Group	4
Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells	4
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients	4
Response of canine thyroid carcinomas to radioiodine	3
Immunoexpression of epithelial membrane antigen in canine meningioma: Novel results for perspective considerations	3
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study	3
Evaluating the relevance of surgical margins. Part one: The problems with current methodology	3
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines	3
Biological behaviour of primary osteosarcoma of the digits, metacarpal and metatarsal bones in dogs	3
Manipulating histone acetylation leads to antitumor effects in hemangiosarcoma cells	3
Association between weight change during initial chemotherapy and clinical outcome in dogs with multicentric lymphoma	3
The second‐generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells	3
A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy	3
The number of glutamines in the N‐terminal of the canine androgen receptor affects signalling intensities	3
Canine Oncopanel: A capture‐based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers	3
KIT mutations in mast cell tumours from cheetahs (Acinonyx jubatus) and domestic cats (Felis catus)	3
Developing a translational murine‐to‐canine pathway for an IL‐2/agonist anti‐CD40 antibody cancer immunotherapy	3
Definitive‐intent radiotherapy for sinonasal carcinoma in cats: A multicenter retrospective assessment	3
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours	3
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas	3
The prevalence of intra‐tumoral and distant thrombi, as well as tumour‐cell emboli in canine neoplasia	3
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate	3
Treatment of canine oral papillary squamous cell carcinoma using definitive‐intent radiation as a monotherapy—a case series	3
The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell lines	3
Long interspersed nucleotide element‐1 hypomethylation in canine malignant mucosal melanoma	3
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC	3
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol	3
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors	3
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review	3
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry	3
Axillary lymphadenectomy in dogs: A description of surgical technique	3
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma	3
Total laryngectomy and permanent tracheostomy in six dogs	3
Familial follicular cell thyroid carcinomas in a large number of Dutch German longhaired pointers	3
Using digital RNA counting to establish flow cytometry diagnostic criteria for subtypes of CD34+ canine acute leukaemia	2
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour	2
Canine lymphoma and vector‐borne diseases: Molecular and serological evaluation of a possible complicity	2
Local tumour nanoparticle thermal therapy: A promising immunomodulatory treatment for canine cancer	2
Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma	2
Inter‐pathologist agreement on diagnosis, classification and grading of canine glioma	2
Hypoxia‐targeting therapy for intestinal T‐cell lymphoma in dogs: Preclinical study using 3D in vitro models	2
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma	2
A prospective randomized trial of desmopressin in canine mammary carcinoma	2
Surgical complications following sentinel lymph node biopsy guided by γ‐probe and methylene blue in 113 tumour‐bearing dogs	2
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs	2
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma	2

In situ c‐KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors	2
Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia	2
Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model	2
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases	2
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines	2
Repeatable and objective method for evaluating angiogenesis using real‐time RT‐PCR of endoglin expression in canine tumours	2
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression	2
Assessment of biomarkers influencing treatment success on small intestinal lymphoma in dogs	2
Organoids of patient‐derived medullary thyroid carcinoma: The first milestone towards a new in vitro model in dogs	2
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs	2
Blood biomarkers for canine cancer, from human to veterinary oncology	2
A retrospective analysis of 11 dogs with surface osteosarcoma	2
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy	2
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs	2
Comparison of response assessment in veterinary neuro‐oncology and two volumetric neuroimaging methods to assess therapeutic brain tumour responses in veterinary patients	2
Identification of potential canine mammary tumour cell biomarkers using proteomic approach: Differences in protein profiles among tumour and normal mammary epithelial cells by two‐dimensional electrop	2
Effect of perioperative desmopressin in cats with mammary carcinoma treated with bilateral mastectomy	2
Atorvastatin preferentially inhibits the growth of high ZEB‐expressing canine cancer cells	2
Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non‐modulated hypofractionated radiation therapy	2
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma	1
Antioxidant 1 copper chaperone gene expression and copper levels in dog osteosarcoma patients	1
	1
Novel surgical approach to neoplastic lesions in the distal part of the urethra: A pilot cadaver study comparing open and hybrid techniques	1
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs	1
Staging canine patients with appendicular osteosarcoma utilizing fluorine‐18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography	1
Prevalence and anatomopathological characterization of cutaneous squamous cell carcinomas with regional and distant metastases in dogs and cats: 20 cases (1985–2020)	1
Biological behaviour and ezrin expression in canine rhabdomyosarcomas: 25 cases (1990‐2012)	1
Expression and prognostic value of TRPM7 in canine mammary tumours	1
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs	1
An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs	1
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity	1
The prognostic significance of metabolic tumour volume and total lesion glycolysis for dogs staged for appendicular osteosarcoma with fluorine‐18 fluorodeoxyglucose positron emission tomography/comput	1
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy	1
Therapeutic potential of the cytosine deaminase::uracil phosphoribosyl transferase/5‐fluorocytosine suicide system for canine melanoma	1
The animal's microbiome and cancer: A translational perspective	1
Validation of oral brushing as a non‐invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis	1
Hormone receptor expression, clinical and histopathological analysis in feline injection site sarcomas	1
Establishment of a BRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer	1
Being rational over blood ratios in veterinary haematology	1
mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders	1
Exploring optical coherence tomography imaging depth to differentiate tissues at surgical margins	1
Histologic margins and the residual tumour classification scheme	1
Lymphotropic nanoparticle magnetic resonance imaging for diagnosing metastatic lymph nodes in dogs with malignant head and neck tumours	1
Histologic margins and the residual tumour classification scheme	1
Reducing margins for abdominopelvic tumours in dogs: Impact on dose‐coverage and normal tissue complication probability	1
Transcriptome sequencing reveals two subtypes of cortisol‐secreting adrenocortical tumours in dogs and identifies CYP26B1 as a potential new therapeutic target	1
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study	1
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma	1
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma	1
Location of the targeted lymph node in a mandibular lymphocentrum: A needle aspiration model in canine cadavers	1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats	1
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential	1
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis	1
Setup error with and without image guidance using two canine intracranial positioning systems for radiation therapy	1
Establishment and characterization of two novel patient‐derived lines from canine high‐grade glioma	1
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy	1
Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours	1
Effect of contrast agent viscosity and massage on success of computed tomography lymphangiography with aqueous contrast for sentinel lymph node identification in healthy dogs	1
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs	1
Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumours	1
Prevalence and potentially prognostic value of C‐circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma	1
	1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine	1
Targeting IRS‐1/mPGES‐1/NOX2 to inhibit the inflammatory response caused by insulin‐like growth factor‐I‐induced activation of NF‐κB and NLR	1
Response from the authors: A prospective randomized trial of desmopressin in canine mammary carcinoma	1
Desmopressin in canine mammary carcinoma: Comments on the importance of the administration route	1
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain	1
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs	1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)	1
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma	1
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma	1
Characterization and function of extracellular vesicles in a canine mammary tumour cell line: Ultracentrifugation versus size exclusion chromatography	1
Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma	1
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes	1
Stereotactic radiotherapy outcomes for intraventricular brain tumours in 11 dogs	1
Prognostic value of sternal lymphadenopathy on malignancy and survival in dogs undergoing splenectomy	1
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk	1
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells	1
Biological behaviour and clinical outcome in 42 cats with sarcoids (cutaneous fibropapillomas)	1
Altered prolactin and androgen receptors expression in companion rat benign mammary tumours	1
Treatment of myeloid neoplasia with doxorubicin and cytarabine in 11 dogs	1
A relatively high proportion of dogs with small apocrine gland anal sac adenocarcinoma (AGASACA) primary tumours present with locoregional lymph node metastasis	1